FDC, a pharma stock, surged over 20% in the last three months, breaking out from an upward Rising Channel formation. Experts suggest it could reach 600 levels soon. The stock hit a record high of Rs 552 on September 2, 2024, but saw mild profit-taking. It remains above key moving averages, indicating bullish momentum.